J Korean Med Sci.  2015 Jul;30(7):960-964. 10.3346/jkms.2015.30.7.960.

Recent Clinical Manifestation and Prognosis of Fungal Endophthalmitis: A 7-Year Experience at a Tertiary Referral Center in Korea

• Kim DY
• Moon HI
• Joe SG
• Kim JG
• Yoon YH
• Lee JY

• KMID: 2164483
• DOI: http://doi.org/10.3346/jkms.2015.30.7.960

Abstract

This study analyzed the recent causes, prognosis, and treatment strategies for fungal endophthalmitis. A retrospective review of patients who were diagnosed with fungal endophthalmitis at our center was conducted. The fungal organisms isolated from each patient and the visual prognosis according to the route of infection and treatment method were analyzed. A total of 40 eyes from 30 patients with fungal endophthalmitis were included in this study. Candida species were the most common causative organisms in 35 of 40 eyes. Endogenous and exogenous endophthalmitis were observed in 33 and 7 eyes, respectively. Pre- and post-treatment best-corrected visual acuity (BCVA) was not significantly different between endogenous endophthalmitis and exogenous endophthalmitis. The 40 eyes were treated using the following modalities: intravitreal antifungal agent injection with intravenous antifungal agent (16 eyes), vitrectomy with intravenous antifungal agent (14 eyes), intravenous antifungal agent alone (9 eyes), and evisceration (1 eye). Post-treatment BCVA only significantly improved after treatment in the vitrectomy group. Candida species were the most common cause of fungal endophthalmitis, irrespective of the route of infection. The visual prognosis of fungal endophthalmitis was generally poor. In conclusion, if the general condition of the patient tolerates a surgical procedure, prompt vitrectomy and intravitreal injection of antifungal agents can improve visual acuity.

Keyword

Candida; Endogenous Fungal Endophthalmitis; Exogenous Fungal Endophthalmitis; Vitrectomy

MeSH Terms

Antifungal Agents/*therapeutic use
Aspergillus/isolation & purification
Candida/*isolation & purification
Endophthalmitis/*drug therapy/*microbiology/pathology/surgery
Eye Infections, Fungal
Fusarium/isolation & purification
Humans
Prognosis
Republic of Korea
Retrospective Studies
Scedosporium/isolation & purification
Tertiary Care Centers
Visual Acuity
*Vitrectomy
Antifungal Agents

Reference

1. Gupta A, Gupta V, Gupta A, Dogra MR, Pandav SS, Ray P, Chakraborty A. Spectrum and clinical profile of post cataract surgery endophthalmitis in north India. Indian J Ophthalmol. 2003; 51:139–145.

2. Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, Athmanathan S, Rao TN. Endophthalmitis Research Group. Microbiologic spectrum and susceptibility of isolates: part II. Posttraumatic endophthalmitis. Am J Ophthalmol. 1999; 128:242–244.

3. Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, Athmanathan S, Rao TN. Endophthalmitis Research Group. Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Am J Ophthalmol. 1999; 128:240–242.

4. Narang S, Gupta A, Gupta V, Dogra MR, Ram J, Pandav SS, Chakrabarti A. Fungal endophthalmitis following cataract surgery: clinical presentation, microbiological spectrum, and outcome. Am J Ophthalmol. 2001; 132:609–617.

5. Apt L, Isenberg SJ. Infectious endophthalmitis after cataract surgery. Br J Ophthalmol. 1994; 78:948–949.

6. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol. 1998; 43:193–224.

7. Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004; 137:725–731.

8. Essman TF, Flynn HW Jr, Smiddy WE, Brod RD, Murray TG, Davis JL, Rubsamen PE. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers. 1997; 28:185–194.

9. Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, Flynn HW Jr. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012; 153:162–166.

10. Chakrabarti A, Shivaprakash MR, Singh R, Tarai B, George VK, Fomda BA, Gupta A. Fungal endophthalmitis: fourteen years' experience from a center in India. Retina. 2008; 28:1400–1407.

11. Wykoff CC, Flynn HW Jr, Miller D, Scott IU, Alfonso EC. microbiology and clinical outcomes. Ophthalmology. 2008; 115:1501–1507. 1507.e1–1507.e2.

12. Pflugfelder SC, Flynn HW Jr, Zwickey TA, Forster RK, Tsiligianni A, Culbertson WW, Mandelbaum S. Exogenous fungal endophthalmitis. Ophthalmology. 1988; 95:19–30.

13. Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories "hand motion" and "counting fingers" using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009; 247:137–142.

14. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007; 27:662–680.

15. Stern WH, Tamura E, Jacobs RA, Pons VG, Stone RD, O'Day DM, Irvine AR. Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases. Ophthalmology. 1985; 92:1701–1709.

16. Srdic N, Radulovic S, Nonkovic Z, Velimirovic S, Cvetkovic L, Vico I. Two cases of exogenous endophthalmitis due to Fusarium moniliforme and Pseudomonas species as associated aetiological agents. Mycoses. 1993; 36:441–444.

17. Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res. 2011; 36:179–189.

18. Menezes AV, Sigesmund DA, Demajo WA, Devenyi RG. Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med. 1994; 154:2093–2097.